{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:49:19Z","timestamp":1778863759080,"version":"3.51.4"},"reference-count":108,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T00:00:00Z","timestamp":1660176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Rafsanjan University of Medical Sciences"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>COVID-19 is one of the progressive viral pandemics that originated from East Asia. COVID-19 or SARS-CoV-2 has been shown to be associated with a chain of physio-pathological mechanisms that are basically immunological in nature. In addition, chemokines have been proposed as a subgroup of chemotactic cytokines with different activities ranging from leukocyte recruitment to injury sites, irritation, and inflammation to angiostasis and angiogenesis. Therefore, researchers have categorized the chemotactic elements into four classes, including CX3C, CXC, CC, and C, based on the location of the cysteine motifs in their structures. Considering the severe cases of COVID-19, the hyperproduction of particular chemokines occurring in lung tissue as well as pro-inflammatory cytokines significantly worsen the disease prognosis. According to the studies conducted in the field documenting the changing expression of CXC and CC chemokines in COVID-19 cases, the CC and CXC chemokines contribute to this pandemic, and their impact could reflect the development of reasonable strategies for COVID-19 management. The CC and the CXC families of chemokines are important in host immunity to viral infections and along with other biomarkers can serve as the surrogates of vaccine-induced innate and adaptive protective responses, facilitating the improvement of vaccine efficacy. Furthermore, the immunogenicity elicited by the chemokine response to adenovirus vector vaccines may constitute the basis of vaccine-induced immune thrombotic thrombocytopaenia.<\/jats:p>","DOI":"10.3390\/vaccines10081299","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T23:05:49Z","timestamp":1660259149000},"page":"1299","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The Chemokines CXC, CC and C in the Pathogenesis of COVID-19 Disease and as Surrogates of Vaccine-Induced Innate and Adaptive Protective Responses"],"prefix":"10.3390","volume":"10","author":[{"given":"Mojgan Noroozi","family":"Karimabad","sequence":"first","affiliation":[{"name":"Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan 7717933777, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gholamhossein","family":"Hassanshahi","sequence":"additional","affiliation":[{"name":"Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan 7717933777, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9751-6710","authenticated-orcid":false,"given":"Nicholas G.","family":"Kounis","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Cardiology, University of Patras Medical School, 26500 Patras, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Mplani","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Patras University Hospital, 26500 Patras, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8884-1370","authenticated-orcid":false,"given":"Pavlos","family":"Roditis","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Mamatsio Kozanis General Hospital, 50100 Kozani, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9598-6954","authenticated-orcid":false,"given":"Christos","family":"Gogos","sequence":"additional","affiliation":[{"name":"COVID-19 Unit, Papageorgiou General Hospital, 56403 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Lagadinou","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Infectious Diseases, University of Patras Medical School, 26500 Patras, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6901-3681","authenticated-orcid":false,"given":"Stelios F.","family":"Assimakopoulos","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Infectious Diseases, University of Patras Medical School, 26500 Patras, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Periklis","family":"Dousdampanis","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Saint Andrews State General Hospital, 26221 Patras, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioanna","family":"Koniari","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospital of South Manchester, NHS Foundation Trust, Manchester M23 9LT, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A Novel Coronavirus from Patients with Pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cytogfr.2020.05.003","article-title":"The cytokine storm in COVID-19: An overview of the involvement of the chemokine\/chemokine-receptor system","volume":"53","author":"Coperchini","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1465-9921-6-135","article-title":"Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells","volume":"6","author":"Chan","year":"2005","journal-title":"Respir. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2249.2004.02415.x","article-title":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome","volume":"136","author":"Wong","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1128\/CVI.00636-12","article-title":"Targeting the \u201ccytokine storm\u201d for therapeutic benefit","volume":"20","author":"Harrison","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_9","first-page":"1904","article-title":"Acute Respiratory Distress Syndrome","volume":"377","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"10942","DOI":"10.1038\/srep10942","article-title":"The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes","volume":"5","author":"Guo","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1164\/rccm.200407-857OC","article-title":"Characterization of cytokine\/chemokine profiles of severe acute respiratory syndrome","volume":"171","author":"Jiang","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1517\/14712598.8.3.269","article-title":"Tumour-immune cell interactions modulated by chemokines","volume":"8","author":"Johrer","year":"2008","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s40200-019-00421-2","article-title":"Serum concentration of angiogenic (CXCL1, CXCL12) and angiostasis (CXCL9, CXCL10) CXC chemokines are differentially altered in normal and gestational diabetes mellitus associated pregnancies","volume":"18","author":"Darakhshan","year":"2019","journal-title":"J. Diabetes Metab. Disord."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"993","DOI":"10.7754\/Clin.Lab.2012.120810","article-title":"Expression of CC chemokines CCL2, CCL5, and CCL11 is associated with duration of disease and complications in type-1 diabetes: A study on Iranian diabetic patients","volume":"59","author":"Jamali","year":"2013","journal-title":"Clin. Lab."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000449427","article-title":"Significant role (s) of CXCL12 and the SDF-1 3\u2032 a genetic variant in the pathogenesis of multiple sclerosis","volume":"23","author":"Karimabad","year":"2016","journal-title":"Neuroimmunomodulation"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s10753-012-9577-8","article-title":"Serum levels of the CC chemokines CCL2, CCL5, and CCL11 in food allergic children with different clinical manifestations","volume":"36","author":"Radman","year":"2013","journal-title":"Inflammation"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.preghy.2019.05.001","article-title":"CXCL9\/CXCL10 angiostasis CXC-chemokines in parallel with the CXCL12 as an angiogenesis CXC-chemokine are variously expressed in pre-eclamptic-women and their neonates","volume":"17","author":"Darakhshan","year":"2019","journal-title":"Pregnancy Hypertens."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"468","DOI":"10.7555\/JBR.31.20150166","article-title":"CC chemokines CCL2, CCL3, CCL4 and CCL5 are elevated in osteoporosis patients","volume":"31","author":"Fatehi","year":"2017","journal-title":"J. Biomed. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s12031-013-9954-2","article-title":"The SDF-1 3\u2019A genetic variation is correlated with elevated intra-tumor tissue and circulating concentration of CXCL12 in glial tumors: A study on Iranian anaplastic astrocytoma and glioblastoma multiforme patients","volume":"50","author":"Moosavi","year":"2013","journal-title":"J. Mol. Neurosci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"100154","DOI":"10.1016\/j.jtauto.2022.100154","article-title":"SARS-CoV2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases","volume":"5","author":"Larionova","year":"2022","journal-title":"J. Transl. Autoimmun."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.csbj.2021.01.034","article-title":"Chemokines and chemokine receptors during COVID-19 infection","volume":"19","author":"Khalil","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/33340","article-title":"Chemokines and leukocyte traffic","volume":"392","author":"Baggiolini","year":"1998","journal-title":"Nature"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/84298","article-title":"Chemokines: Immunology\u2019s high impact factors","volume":"2","author":"Mackay","year":"2001","journal-title":"Nat. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1034\/j.1600-065X.2000.17701.x","article-title":"Chemokines, chemokine receptors and hematopoiesis","volume":"177","author":"Youn","year":"2000","journal-title":"Immunol. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1126\/science.1281554","article-title":"Interleukin-8 as a macrophage-derived mediator of angiogenesis","volume":"258","author":"Koch","year":"1992","journal-title":"Science"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1074-7613(00)80165-X","article-title":"Chemokines: A new classification system and their role in immunity","volume":"12","author":"Zlotnik","year":"2000","journal-title":"Immunity"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"6569","DOI":"10.1021\/bi9602270","article-title":"Heteronuclear (1H, 13C, 15N) NMR assignments and solution structure of the monocyte chemoattractant protein-1 (MCP-1) dimer","volume":"35","author":"Handel","year":"1996","journal-title":"Biochemistry"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrd3048","article-title":"Therapeutic targeting of chemokine interactions in atherosclerosis","volume":"9","author":"Koenen","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1146\/annurev.immunol.24.021605.090529","article-title":"Chemokine: Receptor structure, interactions, and antagonism","volume":"25","author":"Allen","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cytogfr.2014.11.009","article-title":"CXCR3 ligands in disease and therapy","volume":"26","author":"Liekens","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10540-006-9025-9","article-title":"Structural basis of chemokine receptor function\u2014A model for binding affinity and ligand selectivity","volume":"26","author":"Rajagopalan","year":"2006","journal-title":"Biosci. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12016-020-08792-8","article-title":"Clinical Pathway for Early Diagnosis of COVID-19: Updates from Experience to Evidence-Based Practice","volume":"59","author":"Xu","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","article-title":"Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses","volume":"24","author":"Su","year":"2016","journal-title":"Trends Microbiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"105954","DOI":"10.1016\/j.ijantimicag.2020.105954","article-title":"Cytokine release syndrome in severe COVID-19: Interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality","volume":"55","author":"Zhang","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.chom.2016.01.007","article-title":"Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice","volume":"19","author":"Channappanavar","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1164\/rccm.201203-0508OC","article-title":"CXCL10-CXCR3 enhances the development of neutrophil-mediated fulminant lung injury of viral and nonviral origin","volume":"187","author":"IIchikawa","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1189\/jlb.1102577","article-title":"Expression and function of chemokines during viral infections: From molecular mechanisms to in vivo function","volume":"74","author":"Melchjorsen","year":"2003","journal-title":"J. Leukoc. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.virol.2005.09.024","article-title":"The interferon response circuit: Induction and suppression by pathogenic viruses","volume":"344","author":"Haller","year":"2006","journal-title":"Virology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.it.2003.08.006","article-title":"The interferon in TLR signaling: More than just antiviral","volume":"24","author":"Hertzog","year":"2003","journal-title":"Trends Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1089\/vim.2004.17.498","article-title":"Inverse interference: How viruses fight the interferon system","volume":"17","author":"Weber","year":"2004","journal-title":"Viral Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"K\u00fcng, E., Coward, W.R., Neill, D.R., Malak, H.A., M\u00fchlemann, K., Kadioglu, A., Hilty, M., and Hathaway, L.J. (2014). The pneumococcal polysaccharide capsule and pneumolysin differentially affect CXCL8 and IL-6 release from cells of the upper and lower respiratory tract. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0092355"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/jmv.24042","article-title":"Association of interleukin-8 and neutrophils with nasal symptom severity during acute respiratory infection","volume":"87","author":"Henriquez","year":"2015","journal-title":"J. Med. Virol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri980","article-title":"Viral mimicry of cytokines, chemokines and their receptors","volume":"3","author":"Alcami","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cytogfr.2008.01.001","article-title":"Interferon and cytokine responses to SARS-coronavirus infection","volume":"19","author":"Thiel","year":"2008","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00024382-200209000-00010","article-title":"MOB-1 and TNF-alpha interact to induce microvascular lung injury","volume":"18","author":"Rabinovici","year":"2002","journal-title":"Shock"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1165\/rcmb.2008-0348TR","article-title":"Transepithelial migration of neutrophils: Mechanisms and implications for acute lung injury","volume":"40","author":"Zemans","year":"2009","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0031-6865(99)00040-0","article-title":"Chemokine receptors: Interaction with HIV-1 and viral-encoded chemokines","volume":"74","author":"Sozzani","year":"2000","journal-title":"Pharm. Acta Helv."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"L884","DOI":"10.1152\/ajplung.1995.269.6.L884","article-title":"Mob-1 expression in IL-2-induced ARDS: Regulation by TNF-alpha","volume":"269","author":"Neville","year":"1995","journal-title":"Am. J. Physiol.-Lung Cell. Mol. Physiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/CCM.0b013e318207ec3c","article-title":"Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury","volume":"39","author":"Calfee","year":"2011","journal-title":"Crit. Care Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3389\/fgene.2020.00641","article-title":"Neutrophils, Crucial, or Harmful Immune Cells Involved in Coronavirus Infection: A Bioinformatics Study","volume":"11","author":"Hemmat","year":"2020","journal-title":"Front. Genet."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Lee, A.C., Chakladar, J., Li, W.T., Chen, C., Chang, E.Y., Wang-Rodriguez, J., and Ongkeko, W.M. (2020). Tobacco, but Not Nicotine and Flavor-Less Electronic Cigarettes, Induces ACE2 and Immune Dysregulation. Int. J. Mol. Sci., 21.","DOI":"10.1101\/2020.07.13.198630"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12967-020-02695-0","article-title":"Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2","volume":"19","author":"Islam","year":"2021","journal-title":"J. Transl. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s41232-020-00148-1","article-title":"Immunopathogenesis of SARS-CoV-2-induced pneumonia: Lessons from influenza virus infection","volume":"40","author":"Miyazawa","year":"2020","journal-title":"Inflamm. Regen."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e9357","DOI":"10.7717\/peerj.9357","article-title":"Host transcriptome-guided drug repurposing for COVID-19 treatment: A meta-analysis based approach","volume":"8","author":"Loganathan","year":"2020","journal-title":"PeerJ"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Cai, Z., Greene, M.I., Zhu, Z., and Zhang, H. (2020). Structural Features and PF4 Functions that Occur in Heparin-Induced Thrombocytopenia (HIT) Complicated by COVID-19. Antibodies, 9.","DOI":"10.3390\/antib9040052"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"283","DOI":"10.21037\/atm.2017.06.49","article-title":"Biomarkers for the acute respiratory distress syndrome: How to make the diagnosis more precise","volume":"5","author":"Lorente","year":"2017","journal-title":"Ann. Transl. Med."},{"key":"ref_57","first-page":"1121","article-title":"Acute lung injury in patients with traumatic injuries: Utility of a panel of biomarkers for diagnosis and pathogenesis","volume":"68","author":"Fremont","year":"2010","journal-title":"J. Trauma"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0140-6736(93)90416-E","article-title":"Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups","volume":"341","author":"Donnelly","year":"1993","journal-title":"Lancet"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1172\/JCI118009","article-title":"Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms","volume":"96","author":"Folkesson","year":"1995","journal-title":"J. Clin. Investig."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.3389\/fimmu.2020.02145","article-title":"Re-analysis of Single Cell Transcriptome Reveals That the NR3C1-CXCL8-Neutrophil Axis Determines the Severity of COVID-19","volume":"11","author":"Park","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e144455","DOI":"10.1172\/jci.insight.144455","article-title":"An immune-based biomarker signature is associated with mortality in COVID-19 patients","volume":"6","author":"Abers","year":"2021","journal-title":"JCI Insight"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"580987","DOI":"10.3389\/fimmu.2020.580987","article-title":"Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features COVID-19 Aggravation in the Second Week of Illness","volume":"11","author":"Tincati","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Lang, S., Li, L., Wang, X., Sun, J., Xue, X., Xiao, Y., Zhang, M., Ao, T., and Wang, J. (2017). CXCL10\/IP-10 neutralization can ameliorate lipopolysaccharide-induced acute respiratory distress syndrome in rats. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0169100"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Cheemarla, N.R., Brito, A.F., Fauver, J.R., Alpert, T., Vogels, C.B.F., Omer, S.B., Ko, A.I., Grubaugh, N.D., Landry, M.L., and Foxman, E.F. (2020). Host response-based screening to identify undiagnosed cases of COVID-19 and expand testing capacity. medRxiv.","DOI":"10.1101\/2020.06.04.20109306"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"104761","DOI":"10.1016\/j.phrs.2020.104761","article-title":"Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)","volume":"156","author":"Li","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1177\/1073858420941476","article-title":"COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation","volume":"26","author":"Kempuraj","year":"2020","journal-title":"Neuroscientist"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.bbi.2020.05.078","article-title":"A pharmacological interactome between COVID-19 patient samples and human sensory neurons reveals potential drivers of neurogenic pulmonary dysfunction","volume":"89","author":"Ray","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13020-020-00346-6","article-title":"Mechanism of Dayuanyin in the treatment of coronavirus disease 2019 based on network pharmacology and molecular docking","volume":"15","author":"Ruan","year":"2020","journal-title":"Chin. Med."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Gruber, C.N., Patel, R.S., Trachtman, R., Lepow, L., Amanat, F., Krammer, F., Wilson, K.M., Onel, K., Geanon, D., and Tuballes, K. (2020). Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C). medRxiv.","DOI":"10.1101\/2020.07.04.20142752"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/22221751.2020.1747363","article-title":"Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients","volume":"9","author":"Xiong","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41587-020-00796-1","article-title":"Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19","volume":"39","author":"Trump","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Patterson, B.K., Seethamraju, H., Dhody, K., Corley, M.J., Kazempour, K., Lalezari, J., Pang, A.P.S., Sugai, C., Francisco, E.B., and Pise, A. (2020). Disruption of the CCL5\/RANTES-CCR5 Pathway Restores Immune Homeostasis and Reduces Plasma Viral Load in Critical COVID-19. medRxiv.","DOI":"10.1101\/2020.05.02.20084673"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Takahashi, T., Wong, P., Ellingson, M.K., Lucas, C., Klein, J., Israelow, B., Silva, J., Oh, J.E., Mao, T., and Tokuyama, M. (2020). Sex differences in immune responses to SARS-CoV-2 that underlie disease outcomes. medRxiv.","DOI":"10.1101\/2020.06.06.20123414"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"7639","DOI":"10.18632\/aging.103101","article-title":"Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2","volume":"12","author":"Yao","year":"2020","journal-title":"Aging"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"577282","DOI":"10.1016\/j.jneuroim.2020.577282","article-title":"Immunologic characterization of a immunosuppressed multiple sclerosis patient that recovered from SARS-CoV-2 infection","volume":"345","author":"Chiarini","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"145145","DOI":"10.1016\/j.gene.2020.145145","article-title":"Serum CCL17 level becomes a predictive marker to distinguish between mild\/moderate and severe\/critical disease in patients with COVID-19","volume":"766","author":"Sugiyama","year":"2021","journal-title":"Gene"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"R250","DOI":"10.1152\/ajpregu.00324.2020","article-title":"Unique inflammatory profile is associated with higher SARS-CoV-2 acute respiratory distress syndrome (ARDS) mortality","volume":"320","author":"Balnis","year":"2021","journal-title":"Am. J. Physiol.-Regul. Integr. Comp. Physiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/s41587-020-0602-4","article-title":"COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis","volume":"38","author":"Chua","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e2000232","DOI":"10.1002\/bies.202000232","article-title":"Can immunological manipulation defeat SARS-CoV-2? Why G-CSF induced neutrophil expansion is worth a clinical trial: G-CSF treatment against COVID-19","volume":"43","author":"Katayama","year":"2021","journal-title":"BioEssays"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.csbj.2020.12.016","article-title":"Host transcriptomic profiling of COVID-19 patients with mild, moderate, and severe clinical outcomes","volume":"19","author":"Jain","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"752397","DOI":"10.3389\/fimmu.2021.752397","article-title":"Prime-Boost Vaccination with Covaxin\/BBV152 Induces Heightened Systemic Cytokine and Chemokine Responses","volume":"12","author":"Kumar","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1146\/annurev-immunol-032713-120145","article-title":"Chemokines and chemokine receptors: Positioning cells for host defense and immunity","volume":"32","author":"Griffith","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e000599","DOI":"10.1136\/jitc-2020-000599","article-title":"Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-\u03b3, CXCL9 and CXCL10","volume":"8","author":"Bergamaschi","year":"2020","journal-title":"J. Immunother. Cancer."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1172\/JCI125372","article-title":"Innate gene signature distinguishes humoral versus cytotoxic responses to influenza vaccination","volume":"129","author":"Bonduelle","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"109504","DOI":"10.1016\/j.celrep.2021.109504","article-title":"Systemic IL-15, IFN-\u03b3, and IP-10\/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients","volume":"36","author":"Bergamaschi","year":"2021","journal-title":"Cell Rep."},{"key":"ref_86","first-page":"10760296221091770","article-title":"The Relevance of Anti-PF4 Antibody Isotypes and Endogenous Glycosaminoglycans and their Relationship with Inflammatory Biomarkers in Pulmonary Embolism Patients","volume":"28","author":"Kantarcioglu","year":"2022","journal-title":"Clin. Appl. Thromb.\/Hemost."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000053852","article-title":"A comparison of FcepsilonRI-mediated RANTES release from human platelets between allergic patients and healthy individuals","volume":"125","author":"Hasegawa","year":"2001","journal-title":"Int. Arch. Allergy Immunol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1182\/blood.V93.8.2543","article-title":"Functional expression of the high affinity receptor for IgE (FcepsilonRI) in human platelets and its\u2019 intracellular expression in human megakaryocytes","volume":"93","author":"Hasegawa","year":"1999","journal-title":"Blood"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Kounis, N.G., Koniari, I., de Gregorio, C., Assimakopoulos, S.F., Velissaris, D., Hung, M.Y., Mplani, V., Saba, L., Brinia, A., and Kouni, S.N. (2021). COVID-19 Disease, Women\u2019s Predominant Non-Heparin Vaccine-Induced Thrombotic Thrombocytopenia and Kounis Syndrome: A Passepartout Cytokine Storm Interplay. Biomedicines, 9.","DOI":"10.3390\/biomedicines9080959"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.it.2020.10.004","article-title":"Mechanisms of SARS-CoV-2 Transmission and Pathogenesis","volume":"41","author":"Harrison","year":"2020","journal-title":"Trends Immunol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1152\/physiol.00019.2020","article-title":"Pathophysiology of COVID-19: Mechanisms Underlying Disease Severity and Progression","volume":"35","author":"Bohn","year":"2020","journal-title":"Physiology"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-P\u00e9rez, B.E., Gonz\u00e1lez-Rojas, J.A., Salazar, M.I., Torres-Torres, C., and Castrej\u00f3n-Jim\u00e9nez, N.S. (2020). Taming the Autophagy as a Strategy for Treating COVID-19. Cells, 9.","DOI":"10.3390\/cells9122679"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/IPC.0b013e3181d2ee41","article-title":"Cytokine storms: Systemic disasters of infectious diseases","volume":"8","author":"Nazinitsky","year":"2010","journal-title":"Infect. Dis. Clin. Pract."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","article-title":"Pathological inflammation in patients with COVID-19: A key role for monocytes and macrophages","volume":"20","author":"Merad","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1099\/vir.0.055533-0","article-title":"Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: Implications for pathogenesis and treatment","volume":"94","author":"Lau","year":"2013","journal-title":"J. Gen. Virol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1128\/JVI.80.6.2684-2693.2006","article-title":"Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro","volume":"80","author":"Yen","year":"2006","journal-title":"J. Virol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/CIRCULATIONAHA.120.047549","article-title":"The Science Underlying COVID-19: Implications for the Cardiovascular System","volume":"142","author":"Liu","year":"2020","journal-title":"Circulation"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"889693","DOI":"10.3389\/fmicb.2022.889693","article-title":"Autophagy Activation Induces p62-Dependent Autophagic Degradation of Dengue Virus Capsid Protein During Infection","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Microbiol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/cdd.2017.1","article-title":"Autophagy induced by DAMPs facilitates the inflammation response in lungs undergoing ischemia-reperfusion injury through promoting TRAF6 ubiquitination","volume":"24","author":"Liu","year":"2017","journal-title":"Cell Death Differ."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/infdis\/jiaa363","article-title":"Serum cytokine and chemokine profile in relation to the severity of coronavirus disease 2019 in China","volume":"222","author":"Chi","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Liu","year":"2020","journal-title":"Cell"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nri722","article-title":"Chemokine receptors: Multifaceted therapeutic targets","volume":"2","author":"Proudfoot","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/s41590-020-0779-1","article-title":"The dynamic changes in cytokine responses in COVID-19: A snapshot of the current state of knowledge","volume":"21","author":"Buszko","year":"2020","journal-title":"Nat. Immunol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41392-020-0211-1","article-title":"Temporal profiling of plasma cytokines, chemokines and growth factors from mild, severe and fatal COVID-19 patients","volume":"5","author":"Xu","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e139834","DOI":"10.1172\/jci.insight.139834","article-title":"Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease","volume":"5","author":"Zhao","year":"2020","journal-title":"JCI Insight"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"e138070","DOI":"10.1172\/jci.insight.138070","article-title":"Clinical and pathological investigation of patients with severe COVID-19","volume":"5","author":"Li","year":"2020","journal-title":"JCI Insight"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jaci.2020.04.027","article-title":"Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19","volume":"146","author":"Yang","year":"2020","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/8\/1299\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:07:07Z","timestamp":1760141227000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/8\/1299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,11]]},"references-count":108,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["vaccines10081299"],"URL":"https:\/\/doi.org\/10.3390\/vaccines10081299","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,11]]}}}